Benralizumab Receives FDA Approval as Add-On Maintenance Therapy for Asthma
The FDA approval of benralizumab for patients ages 6 to 11 with asthma follows the conclusions of the phase 3 TATE study.
Source: hcplive.com
📰 Aged 6 News
Aged 6 News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aged 6. Real-time updates on events, politics, business and more.